Candidemia: incidence rates, type of species, and risk factors at a tertiary care academic hospital in China

被引:38
作者
Wu, Zengbin [1 ]
Liu, Yingbin [2 ]
Feng, Xiaobo [3 ]
Liu, Ying [4 ]
Wang, Shuyun [1 ]
Zhu, Xiaodong [5 ]
Chen, Qiqi [1 ]
Pan, Shuming [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Coll Med, Emergency Dept, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Xinhua Hosp, Coll Med, Dept Surg, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Xinhua Hosp, Coll Med, Dept Dermatol, Shanghai 200030, Peoples R China
[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Coll Med, Dept Clin Microbiol, Shanghai 200030, Peoples R China
[5] Shanghai Jiao Tong Univ, Xinhua Hosp, Coll Med, Dept Pediat, Shanghai 200030, Peoples R China
关键词
Candidemia; Incidence; Candid albicans; Candida guilliermondii; BLOOD-STREAM INFECTIONS; SUSCEPTIBILITY; GUILLIERMONDII; EPIDEMIOLOGY; SURVEILLANCE; PROGRAM;
D O I
10.1016/j.ijid.2013.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate the incidence rates of candidemia in hospitalized patients and to identify differences in risk factors of patients with Candida albicans and non-C. albicans and with Candida guilliermondii and non-C. guilliermondii candidemia. Methods: Non-immunosuppressed, non-neutropenic inpatients with candidemia diagnosed after admission were included in this retrospective observational study at a tertiary academic hospital in China. Results: During the study period (January 2009 to December 2011), 238 eligible patients had candidemia episodes with an incidence rate 5.4%. Of these patients, 29.8% had candidemia due to C. albicans, 27.7% due to C. parapsilosis, and 16.4% due to C. guilliermondii. Diabetes was a significant risk factor for patients with candidemia due to C. albicans (35.2%, 25/71) compared to candidemia due to non-C. albicans spp (13.2%, 22/167) (odds ratio (OR) 0.2792, 95% confidence interval (CI) 0.144-0.5412; p < 0.001). Compared to patients with candidemia due to non-C. guilliermondii spp, preterm birth with low birth weight (OR 0.0887, 95% CI 0.0398-0.1977; p < 0.001), intravenous nutrition (OR 0.0662, 95% CI 0.0226-0.1938), and surgery (OR 0.0662, 95% CI 0.0226-0.1938; p < 0.001) were significant risk factors for candidemia due to C. guilliermondii. Furthermore, compared to patients with candidemia due to C. albicans, patients with candidemia due to C. guilliermondii had markedly higher rates of central venous catheterization (85.9%, 61/71 vs. C. guilliermondii: 100%, 39/39; p = 0.013) and intravenous nutrition (89.7%, 35/39 vs. C. albicans: 42.2%, 30/71; p < 0.001). Conclusions: Candidemia due to C. albicans ranks first in incidence, and candidemia due to C. guilliermondii occurs in a significant proportion of our hospitalized patients. (C) 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. All rights reserved.
引用
收藏
页码:4 / 8
页数:5
相关论文
共 19 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]   Effects of caspofungin against Candida guilliermondii and Candida parapsilosis [J].
Barchiesi, Francesco ;
Spreghini, Elisabetta ;
Tomassetti, Serena ;
Della Vittoria, Agnese ;
Arzeni, Daniela ;
Manso, Esther ;
Scalise, Giorgio .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) :2719-2727
[3]   Echinocandin Resistance in Candida Species: Mechanisms of Reduced Susceptibility and Therapeutic Approaches [J].
Beyda, Nicholas D. ;
Lewis, Russell E. ;
Garey, Kevin W. .
ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) :1086-1096
[4]  
Borg-von ZM, 2007, ANTIMICROB CHEMOTHER, V60, P424
[5]   Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii) [J].
Desnos-Ollivier, Marie ;
Ragon, Marie ;
Robert, Vincent ;
Raoux, Dorothee ;
Gantier, Jean-Charles ;
Dromer, Francoise .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (10) :3237-3242
[6]   Cochrane corner [J].
Hamilton, Helen C. ;
Foxcroft, D. R. .
ANESTHESIA AND ANALGESIA, 2008, 106 (01) :345-345
[7]  
Kibbler CC, 1996, PRINCIPLES PRACTICE
[8]  
Lo SM, 2012, WORLD J EMERG MED, V3, P251, DOI [10.5847/wjem.j.1920-8642.2012.04.002, 10.5847/wjem.j.issn.1920-8642.2012.04.002]
[9]  
Ma Xiao-lu, 2006, Zhonghua Er Ke Za Zhi, V44, P694
[10]   Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals [J].
Macphail, GLP ;
Taylor, GD ;
Buchanan-Chell, M ;
Ross, C ;
Wilson, S ;
Kureishi, A .
MYCOSES, 2002, 45 (5-6) :141-145